These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 33220615)
1. Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Uprety P; Mathew J; Weinstein MP; Kirn TJ Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115196. PubMed ID: 33220615 [No Abstract] [Full Text] [Related]
2. Comparison of the simultaneous conjunctiva and oropharynx-nasopharynx swab results in patients applying to the SARS-CoV-2 outpatient clinic for the first time. Gunduz A; Firat M; Turkoglu G J Med Virol; 2021 Jul; 93(7):4516-4522. PubMed ID: 33783859 [TBL] [Abstract][Full Text] [Related]
3. Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity. Pan D; Sze S; Rogers B; Bron J; Bird PW; Holmes CW; Tang JW J Infect; 2020 Dec; 81(6):979-997. PubMed ID: 32956734 [No Abstract] [Full Text] [Related]
4. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab. Pagella F; Lizzio R; Ugolini S; Spinozzi G; Maiorano E; Suppressa P; Sabbà C; Matti E Orphanet J Rare Dis; 2020 Dec; 15(1):350. PubMed ID: 33339521 [TBL] [Abstract][Full Text] [Related]
5. Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2. Shakir SM; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Hanson KE J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087437 [No Abstract] [Full Text] [Related]
6. Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument. Boutin CA; Grandjean-Lapierre S; Gagnon S; Labbé AC; Charest H; Roger M; Coutlée F J Clin Virol; 2020 Nov; 132():104615. PubMed ID: 32927356 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. Kociolek LK; Muller WJ; Yee R; Dien Bard J; Brown CA; Revell PA; Wardell H; Savage TJ; Jung S; Dominguez S; Parikh BA; Jerris RC; Kehl SC; Campigotto A; Bender JM; Zheng X; Muscat E; Linam M; Abuogi L; Smith C; Graff K; Hernandez-Leyva A; Williams D; Pollock NR J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33093026 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of nasopharyngeal, oropharyngeal, and nasal wash specimens for SARS-CoV-2 detection in the setting of sampling device shortage. Calame A; Mazza L; Renzoni A; Kaiser L; Schibler M Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):441-445. PubMed ID: 32939576 [TBL] [Abstract][Full Text] [Related]
9. Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA. Eberle U; Wimmer C; Huber I; Neubauer-Juric A; Valenza G; Ackermann N; Sing A; Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1303-1308. PubMed ID: 33512617 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the BioFire® COVID-19 test and Respiratory Panel 2.1 for rapid identification of SARS-CoV-2 in nasopharyngeal swab samples. Eckbo EJ; Locher K; Caza M; Li L; Lavergne V; Charles M Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115260. PubMed ID: 33340934 [TBL] [Abstract][Full Text] [Related]
11. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay. Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384 [TBL] [Abstract][Full Text] [Related]
12. Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens. Wang H; Hogan CA; Miller JA; Sahoo MK; Huang C; Mfuh KO; Sibai M; Zehnder J; Hickey B; Sinnott-Armstrong N; Pinsky BA Emerg Infect Dis; 2021 Jan; 27(1):92-103. PubMed ID: 33183494 [TBL] [Abstract][Full Text] [Related]
13. Inhale, then exhale: start afresh to diagnose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by non-invasive face-mask sampling technique. Kanaujia R; Biswal M; Angrup A; Ray P Clin Microbiol Infect; 2020 Dec; 26(12):1701-1702. PubMed ID: 32629023 [No Abstract] [Full Text] [Related]
14. An Ultra-Rapid Real-Time RT-PCR Method Using the PCR1100 to Detect Severe Acute Respiratory Syndrome Coronavirus-2. Shirato K; Nao N; Matsuyama S; Takeda M; Kageyama T Jpn J Infect Dis; 2021 Jan; 74(1):29-34. PubMed ID: 32611983 [TBL] [Abstract][Full Text] [Related]
15. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak. Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877 [TBL] [Abstract][Full Text] [Related]
16. Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR. Kim SY; Lee J; Sung H; Lee H; Han MG; Yoo CK; Lee SW; Hong KH Emerg Infect Dis; 2020 Oct; 26(10):2469-2472. PubMed ID: 32844739 [TBL] [Abstract][Full Text] [Related]
17. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs. Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455 [No Abstract] [Full Text] [Related]
18. COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies. Bustin S; Mueller R; Shipley G; Nolan T Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671091 [TBL] [Abstract][Full Text] [Related]
19. Diagnostics in the Time of Coronavirus Disease 2019 (COVID-19): Challenges and Opportunities. Zehnbauer B J Mol Diagn; 2021 Jan; 23(1):1-2. PubMed ID: 33349346 [No Abstract] [Full Text] [Related]
20. Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization. Lefferts JA; Allen SF; Steinmetz HB; Tsongalis GJ Clin Chem; 2021 Jan; 67(2):434-435. PubMed ID: 33315063 [No Abstract] [Full Text] [Related] [Next] [New Search]